搜索临床试验以:epidermal growth factor receptor tyrosine inhibitor
总计103347个结果
-
Gustave Roussy, Cancer Campus, Grand Paris未知
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKline完全的
-
National Taiwan University HospitalNational Science Council, Taiwan完全的
-
Lymphoma Study Association终止CD20-Positive Large B-Cell Lymphoma法国
-
National Taiwan University HospitalNational Science Council, Taiwan完全的
-
National Taiwan University Hospital未知
-
National Taiwan University Hospital完全的
-
Mylan Bertek Pharmaceuticals完全的
-
Centers for Disease Control and PreventionUS Department of Veterans Affairs完全的
-
Centers for Disease Control and PreventionUS Department of Veterans Affairs完全的
-
Menzies School of Health ResearchNational Health and Medical Research Council, Australia; Wellcome Trust; National Institute of...完全的
-
Centers for Disease Control and PreventionNational Institute of Allergy and Infectious Diseases (NIAID); Alaska Native Tribal Health Consortium 和其他合作者完全的
-
Centers for Disease Control and PreventionKenya Medical Research Institute完全的
-
University of AarhusLundbeck Foundation; Sygekassernes Helsefond; Ringkjobing Amt; Ribe Amt完全的
-
Centers for Disease Control and PreventionUS Department of Veterans Affairs完全的
-
Hospital de SabadellBristol-Myers Squibb未知
-
Centers for Disease Control and PreventionUS Department of Veterans Affairs完全的
-
Titan Pharmaceuticals终止
-
Titan Pharmaceuticals完全的
-
Centers for Disease Control and PreventionUniversity of Alabama at Birmingham; Universidad del Valle, Guatemala完全的
-
Centers for Disease Control and PreventionMinistry of Health and Population, Malawi完全的
-
East Valley Hematology and Oncology Medical GroupAstex Pharmaceuticals, Inc.; Pharmatech Oncology; Mena, Raul, M.D.未知